Alexis, A. F., Yamauchi, P. S., Lin, T. and Martin, G. (2019) “Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis in a Hispanic Population: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials”, SKIN The Journal of Cutaneous Medicine, 3, p. S28. doi: 10.25251/skin.3.supp.28.